About Syrna Therapeutics
Syrna Therapeutics is a private company based in Del Mar, California, incorporated in 2020 in Delaware. It has reported $10,884,674 raised in one offering on Form D since August 2023. Its chief executive is David Weitz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 2, 2023 | Aug 10, 2023 | $10,884,674fully sold | 3 | $3.6M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Syrna Therapeutics's Form D filed Aug 10, 2023.
TH
Thomas Hermann
Director
AA
Aiden Aceves
Director
JD
Joel Dudley
Director
DW
David Weitz
Chief Executive Officer and director